Table 2.
Unweighted | Weighted | |||||
---|---|---|---|---|---|---|
Model | HR | 95% CI | p-Value | HR | 95% CI | p-Value |
Outcome: Eating disorder (composite) | ||||||
Transfeminine | 1.17 | 0.99, 1.38 | 0.06 | 1.67** | 1.41, 1.98 | <0.001 |
Transmasculine | 0.57 | 0.53, 0.62 | <0.001 | 0.83** | 0.76, 0.90 | <0.001 |
Outcome: Anorexia nervosa | ||||||
Transfeminine | 1.41 | 1.00, 1.97 | 0.047 | 1.94** | 1.37, 2.74 | <0.001 |
Transmasculine | 0.51 | 0.43, 0.60 | <0.001 | 0.73** | 0.62, 0.86 | <0.001 |
Outcome: Bulimia | ||||||
Transfeminine | 0.86 | 0.54, 1.37 | 0.525 | 1.18 | 0.73, 1.89 | 0.504 |
Transmasculine | 0.66 | 0.51, 0.85 | 0.002 | 0.89 | 0.68, 1.17 | 0.423 |
Outcome: Binge eating | ||||||
Transfeminine | 1.45 | 0.84, 2.50 | 0.180 | 1.74 | 1.00, 3.02 | 0.051 |
Transmasculine | 0.89 | 0.64, 1.23 | 0.471 | 1.13 | 0.81, 1.57 | 0.487 |
Result shown both before and after inverse probability treatment weighting.